SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-019415
Filing Date
2022-08-08
Accepted
2022-08-08 17:27:44
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20220630_10q.htm   iXBRL 10-Q 1418559
2 EXHIBIT 3.3 ex_404948.htm EX-3.3 9859
3 EXHIBIT 10.4 ex_405687.htm EX-10.4 70880
4 EXHIBIT 31.1 ex_381323.htm EX-31.1 16829
5 EXHIBIT 31.2 ex_389860.htm EX-31.2 17146
6 EXHIBIT 32.1 ex_381324.htm EX-32.1 13082
12 pipeline2022q2.jpg GRAPHIC 1221338
  Complete submission text file 0001437749-22-019415.txt   8990112

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20220630.xsd EX-101.SCH 56620
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20220630_cal.xml EX-101.CAL 44372
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20220630_def.xml EX-101.DEF 386398
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20220630_lab.xml EX-101.LAB 344356
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20220630_pre.xml EX-101.PRE 415503
66 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20220630_10q_htm.xml XML 1084005
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 221145607
SIC: 2836 Biological Products, (No Diagnostic Substances)